Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
for
Major Depressive Disorder
Location: Dallas TX, Wichita Falls TX, Oklahoma City OK,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06223880
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Dallas TX, Denton TX, Round Rock TX, Houston TX,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase3, Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Location: Dallas TX, Willow Park TX, Tyler TX, Austin TX,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT07064759
Phase3, Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
for
Macular Edema
Location: Dallas TX, Southlake TX, Austin TX, The Woodlands TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06962839
Phase2, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Dallas TX, Southlake TX, Tyler TX, Round Rock TX,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
for
Macular Telangiectasia Type 2 (MacTel)
Location: Dallas TX, Houston TX, Lakewood CO, Atlanta GA,
Sponsor: Neurotech Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06971939
Recruiting
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
for
LCA5
Location: Dallas TX, Philadelphia PA
Sponsor: Opus Genetics, Inc
Sex: All
Age: 4+
Code: NCT05616793
Phase1, Phase2, Recruiting
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Location: Dallas TX, Madison WI, Miami FL, Los Angeles CA,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 18+
Code: NCT06789445
Phase1, Phase2, Recruiting
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Dallas TX, Oak Forest IL, La Crosse WI, Durham NC,
Sponsor: Complement Therapeutics
Sex: All
Age: 55+
Code: NCT07144137
Recruiting
Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries
for
Head Injuries, Closed
Location: Dallas TX, Houston TX, Toronto
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 0 - 12
Code: NCT00006128
Recruiting
Improving Control of Intermittent Exotropia
for
Intermittent Exotropia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 4 - 10
Code: NCT07272005
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Dallas TX, Richardson TX, Fort Worth TX, Springfield MO,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase3, Recruiting
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Dallas TX, Cincinnati OH, Los Angeles CA, New York NY
Sponsor: Opus Genetics, Inc
Sex: All
Age: 18+
Code: NCT07185256
Phase1, Phase2, Recruiting
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
for
Stargardt Disease
Location: Dallas TX, Bellaire TX, Rochester MN, Phoenix AZ,
Sponsor: AAVantgarde Bio Srl
Sex: All
Age: 8 - 55
Code: NCT07161544
Phase1, Phase2, Recruiting
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
for
RCC, Renal Cell Carcinoma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT05931393
Phase2, Recruiting
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
for
Geographic Atrophy (GA)
Location: Dallas TX, Austin TX, The Woodlands TX, Lakewood CO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50+
Code: NCT07230834
Phase1, Recruiting
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Dallas TX, Southaven MS, Chicago IL, Cincinnati OH,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Dallas TX, Cincinnati OH, Phoenix AZ
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 6+
Code: NCT07734064
Phase1, Recruiting
Binocular Amblyopia Treatment
for
Amblyopia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 4 - 10
Code: NCT03288948
Recruiting
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)